Symptoms-to-emergency-call timing delay in acute coronary syndrome before and during COVID-19: independent predictors and their impact on mortality.
Minerva Cardiology and Angiology · 2022-10-28 · Observational study
Abstract
BACKGROUND: The COVID-19 pandemic severely impacted global health. The aim of this study was to compare predictors of symptoms-to-emergency-call timing delay in acute coronary syndrome (ACS) and their impact on mortality before and during the COVID-19 outbreak. METHODS: We collected sociodemographic, clinical data, procedural features, preadmission and intra-hospital outcomes of consecutive patients admitted for ACS in seventeen Italian centers from March to April 2018, 2019, and 2020. RESULTS: In 2020, a 32.92% reduction in ACS admissions was observed compared to 2018 and 2019. Unstable angina, typical and atypical symptoms, and intermittent angina were identified as significant predictors of symptoms-to-emergency-call timing delay before and during the COVID-19 pandemic (P<0.005 for all the items). Differently from 2018-2019, during the pandemic, hypertension and dyspnea (P=0.002 versus P=0.490 and P=0.001 vs. P=0.761 for 2018-2019 and 2020, respectively) did not result as predictors of delay in symptoms-to-emergency-call timing. Among these predictors, only the atypical symptoms (HR 3.36; 95% CI: 1.172-9.667, P=0.024) in 2020 and the dyspnea (HR 2.64; 95% CI: 1.345-5.190, P=0.005) in 2018-2019 resulted significantly associated with higher mortality. Finally, the family attendance at the onset of the symptoms resulted in a reduction in symptoms-to-emergency-call timing (in 2020 P<0.001; CI: -1710.73; -493.19) and in a trend of reduced mortality (HR 0.31; 95% CI: 0.089-1.079, P=0.066) in 2020. CONCLUSIONS: During the COVID-19 outbreak, atypical symptoms and family attendance at ACS onset were identified, respectively, as adverse and favorable predictors of symptoms-to-emergency-call timing delay and mortality.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
COVID-19 pandemic · Mortality & survival · Time intervals
Related articles
- Effect of the COVID-19 pandemic on mortality of patients with STEMI: a systematic review and meta-analysis. (Heart, 2020)
- COVID-19-mediated patient delay caused increased total ischaemic time in ST-segment elevation myocardial infarction. (Neth Heart J, 2022)
- COVID-19 pandemic and STEMI: pathway activation and outcomes from the pan-London heart attack group. (Open Heart, 2020)
- Effect of COVID-19 outbreak on the treatment time of patients with acute ST-segment elevation myocardial infarction. (Am J Emerg Med, 2021)
- Prehospital tele-electrocardiographic triage improves the management of acute coronary syndrome in rural populations: A systematic review and meta-analysis. (J Telemed Telecare, 2022)
- Time-to-reperfusion in patients with acute myocardial infarction and mortality in prehospital emergency care: meta-analysis. (BMC Emerg Med, 2020)